1. Home
  2. FNRN vs ADAG Comparison

FNRN vs ADAG Comparison

Compare FNRN & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northern Community Bancorp Common stock

FNRN

First Northern Community Bancorp Common stock

N/A

Current Price

$17.50

Market Cap

277.4M

Sector

Finance

ML Signal

N/A

Logo Adagene Inc.

ADAG

Adagene Inc.

N/A

Current Price

$1.74

Market Cap

222.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNRN
ADAG
Founded
1910
2011
Country
United States
China
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
277.4M
222.2M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
FNRN
ADAG
Price
$17.50
$1.74
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $9.91
AVG Volume (30 Days)
125.3K
★ 300.8K
Earning Date
10-29-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 2.42
N/A
EPS
★ 1.02
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$129.59
P/E Ratio
$17.02
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.72
$1.27
52 Week High
$19.25
$4.85

Technical Indicators

Market Signals
Indicator
FNRN
ADAG
Relative Strength Index (RSI) 54.39 37.17
Support Level $16.19 N/A
Resistance Level $18.49 $4.16
Average True Range (ATR) 0.92 0.32
MACD 0.03 -0.04
Stochastic Oscillator 54.55 33.94

Price Performance

Historical Comparison
FNRN
ADAG

About FNRN First Northern Community Bancorp Common stock

First Northern Community Bancorp is a bank holding company for a community bank, First Northern Bank of Dixon. It conducts general banking activities, including collecting deposits and originating loans, and serves Solano, Yolo, Sacramento, Placer, El Dorado, and Contra Costa Counties. It offers a broad range of alternative investment products and services, equipment leasing, credit cards, merchant card processing, payroll services, and limited international banking services. The bank generates the majority of its revenue by providing various products and services to small and medium-sized businesses and individuals. including accepting demand, interest bearing transaction, savings, and time deposits, and making commercial, consumer, and real estate-related loans.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: